Novavax Kicks Off 10,000 Patient Covid Vaccine Study in U.K.

(Bloomberg) -- Novavax Inc. climbed as much as 6.7% in extended trading on plans to start enrolling participants for a late-stage study of its experimental shot for the novel coronavirus in 10,000 ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.